Simulations Plus, Inc. (SLP)
NASDAQHealth CareSoftware - ApplicationSnapshot 2026-09-04
$18.43+0.05%
Close 2026-09-04 · 1-day change
NASDAQHealth CareSoftware - ApplicationSnapshot 2026-09-04
QuarterlyIQ Insights · SLP
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Aug 2025 | Aug 2024 | Aug 2023 | Aug 2022 | Aug 2021 | Aug 2020 | Aug 2019 | Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | Aug 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||
| Revenues | 82.1 | 79.2 | 70.0 | 59.6 | 53.9 | 46.5 | 41.6 | 34.0 | 29.7 | 24.1 | 20.0 | 18.3 | 11.5 |
| Total Revenues | — | — | — | 59.6 | 53.9 | 46.5 | 41.6 | 34.0 | 29.7 | 24.1 | 20.0 | 18.3 | 11.5 |
| Cost of Revenues | 30.1 | 33.0 | 26.9 | 11.6 | 10.8 | 10.6 | 10.6 | 9.0 | 8.0 | 6.3 | 4.6 | 4.4 | 1.6 |
| Gross Profit | 52.0 | 46.2 | 43.2 | 47.9 | 43.1 | 35.9 | 30.9 | 24.9 | 21.7 | 17.8 | 15.4 | 13.9 | 9.8 |
| Operating Expenses & Income | |||||||||||||
| Selling, General & Admin | 17.7 | 20.9 | 22.4 | 27.7 | 20.1 | 20.6 | 16.4 | 11.8 | 9.6 | 8.2 | 6.7 | 6.7 | 4.4 |
| R&D Expenses | 11.5 | 6.9 | 5.8 | 4.5 | 3.2 | 4.0 | 3.0 | 2.5 | 1.8 | 1.4 | 1.4 | 1.3 | 1.0 |
| Other Operating Expenses, Total | — | — | — | 3.0 | 0.2 | (0.2) | (0.2) | — | — | — | — | — | — |
| Operating Income | 11.5 | (70.7) | 6.1 | 8.7 | 14.9 | 11.3 | 11.6 | 10.6 | 10.3 | 8.3 | 7.2 | 5.9 | 4.4 |
| Earnings from Continuing Operations | |||||||||||||
| Interest Expense | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | — | — | — |
| Interest & Investment Income | 1.1 | 0.7 | — | 4.1 | — | — | — | — | — | — | — | — | — |
| Other Non-Operating Income / Expenses | 1.1 | 1.4 | 6.3 | 3.0 | 0.2 | (0.2) | (0.2) | (0.1) | — | — | — | — | 0.0 |
| Asset Writedown | — | 77.2 | — | 0.5 | — | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | 12.6 | (69.4) | 12.4 | 11.7 | 15.1 | 11.1 | 11.4 | 10.6 | 10.1 | 8.2 | 7.2 | 5.7 | 4.5 |
| Income Tax Expense | 4.4 | (4.7) | 2.5 | 1.7 | 2.6 | 1.3 | 2.1 | 2.0 | 1.2 | 2.5 | 2.3 | 1.8 | 1.5 |
| Net Income | |||||||||||||
| Net Income | 8.1 | (64.7) | 10.0 | 10.0 | 12.5 | 9.8 | 9.3 | 8.6 | 8.9 | 5.8 | 5.0 | 3.8 | 3.0 |
| Per Share | |||||||||||||
| Basic EPS | 0.40 | (3.22) | 0.50 | 0.50 | 0.62 | 0.49 | 0.52 | 0.49 | 0.52 | 0.34 | 0.29 | 0.23 | 0.19 |
| Diluted EPS | 0.40 | (3.22) | 0.49 | 0.49 | 0.60 | 0.47 | 0.50 | 0.48 | 0.50 | 0.33 | 0.29 | 0.23 | 0.18 |
| Revenue per Share | 4.05 | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 20.2 | 20.1 | 20.0 | 20.1 | 20.2 | 20.0 | 17.8 | 17.5 | 17.3 | 17.2 | 17.0 | 16.9 | 16.2 |
| Diluted Weighted Avg Shares | 20.2 | 20.1 | 20.3 | 20.5 | 20.7 | 20.7 | 18.5 | 18.1 | 17.9 | 17.5 | 17.2 | 17.0 | 16.4 |
| Supplemental | |||||||||||||
| EBITDA | — | (62.5) | 11.8 | 12.6 | 18.5 | 14.8 | 14.6 | 13.4 | 13.0 | 10.4 | 9.2 | 6.1 | 4.5 |
| EBIT | 11.5 | (70.7) | 6.1 | 8.7 | 14.9 | 11.3 | 11.6 | 10.6 | 10.3 | 8.3 | 7.2 | 5.9 | 4.4 |
| Effective Tax Rate | 35.4% | — | — | 14.8% | 17.4% | 11.8% | 18.0% | 18.7% | 11.9% | 29.8% | 31.6% | 32.5% | 33.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.